GoodRx Holdings, Inc. (GDRX)
Stock Price Chart
Key Info
| Market Cap | 19.69B |
| Revenue (ttm) | 471.70M |
| Net Income (ttm) | 89.53M |
| Shares Out | 384.04M |
| EPS (ttm) | 0.23 |
| PE Ratio | 222.13 |
| Forward PE | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
Stock Quote
| Trading Day | Oct 21, 2020 |
| Last Price | $51.09 |
| Previous Close | $49.05 |
| Change ($) | 2.04 |
| Change (%) | 4.16% |
| Day's Open | 48.89 |
| Day's Range | 48.61 - 51.97 |
| Day's Volume | 1,202,385 |
| 52-Week Range | 45.50 - 64.22 |
More Stats
| Market Cap | 19.69B |
| Enterprise Value | 20.30B |
| Earnings Date (est) | n/a |
| Ex-Dividend Date | n/a |
| Shares Outstanding | 384.04M |
| Float | 36.78M |
| EPS (basic) | n/a |
| EPS (diluted) | 0.23 |
| FCF / Share | n/a |
| Dividend | n/a |
| Dividend Yield | n/a |
| Earnings Yield | 0.45% |
| FCF Yield | n/a |
| Payout Ratio | n/a |
| Shares Short | 1.92M |
| Short Ratio | 0.22 |
| Short % of Float | 5.22% |
| Beta | n/a |
| PE Ratio | 222.13 |
| Forward PE | n/a |
| P/FCF Ratio | n/a |
| PS Ratio | 41.74 |
| PB Ratio | n/a |
| Revenue | 471.70M |
| Operating Income | n/a |
| Net Income | 89.53M |
| Free Cash Flow | n/a |
| Net Cash | -609.66M |
| Net Cash / Share | -1.58 |
| Gross Margin | 79.33% |
| Operating Margin | n/a |
| Profit Margin | 18.98% |
| FCF Margin | n/a |
| ROA | n/a |
| ROE | n/a |
| ROIC | n/a |
Analyst Summary
Analyst Consensus: Overweight
Financial Performance
Financial Overview
| Year | 2019 | 2018 |
|---|---|---|
| Revenue | 388 | 250 |
| Revenue Growth | 55.59% | - |
| Gross Profit | 374 | 243 |
| Operating Income | 140 | 77.25 |
| Net Income | 42.44 | 13.80 |
| Shares Outstanding | 227 | 112 |
| Earnings Per Share | 0.18 | 0.12 |
| EPS Growth | 50% | - |
| Operating Cash Flow | 83.29 | 45.25 |
| Capital Expenditures | -5.75 | -3.46 |
| Free Cash Flow | 77.54 | 41.80 |
| Cash & Equivalents | 26.05 | 34.60 |
| Total Debt | 711 | 722 |
| Net Cash / Debt | -685 | -688 |
| Assets | 387 | 315 |
| Liabilities | 737 | 740 |
| Book Value | -1,088 | -1,162 |
Company Profile
Company Details
| Full Name | GoodRx Holdings, Inc. |
| Country | United States |
| Employees | 338 |
| CEO | Douglas Joseph Hirsch / Trevor Bezdek |
Stock Information
| Ticker Symbol | GDRX |
| Stock Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Health Information Services |
| Unique Identifier | NASDAQ: GDRX |
| IPO Date | September 23, 2020 |
Description
GoodRx Holdings is a holding company. The company, through its subsidiaries, owns and operates a prescription drug price comparison platform using data from local and mail-order pharmacies in the United States. It also provides pharmacy coupons to customers. The company offers generic and brand name pricing; alerts clients on manufacturer co-pay cards, pharmacy discounts, and state discount programs; and provides tips on slashing drug prices. It provides prices of drugs in areas of alcohol dependence, allergies, cold, Alzheimer's disease, angina, antibiotics, anticoagulant, antiviral, antiplatelet, anxiety, arrhythmia, arrhythmia, asthma, bipolar disorder, birth control, cancer, cerebral hemorrhage, cholesterol, COPD, depression, dermatology, diabetes, ear, enlarged prostate, epilepsy, eye, fertility, fibromyalgia, flu, gastrointestinal, heart failure, hypertension, hypotension, immune system, insomnia, medical supplies, men's health, mental health, migraine, myasthenia gravis, nausea, nervous system, obesity, obsessive-compulsive disorder, opioid dependence, pain relief, arthritis, panic disorder, Parkinson's disease, PMDD, restless leg syndrome, schizophrenia, seizure, sleep aids, smoking and addiction, smoking cessation, thyroid drugs, Tourette syndrome, trazodone, urology, vaccines, and women's health. GoodRx Holdings, Inc. was incorporated in 2015 and is based in Santa Monica, California.